abstract |
The present invention provides stable actin IIB receptor polypeptides and proteins that can bind to actin A, myostatin, or GDF-11 to inhibit its activity. The present invention also provides polynucleotides, vectors and host cells capable of producing stable polypeptides and proteins. Also provided are compositions and methods for treating muscle weakness diseases and metabolic disorders. |